NDC 63323-322-01 - Imipenem and Cilastatin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-322
- Requested NDC
- 63323-322-01
- Package NDCs from labels
- 63323-322-21, 63323-322-93, 63323-322-41, 63323-322-94, 63323-322-01, 63323-322-25
- Manufacturer
- Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd
- Effective date
- 2022-10-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 2022-10-11 | HUMAN PRESCRIPTION DRUG LABEL |
| IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 2022-10-10 | HUMAN PRESCRIPTION DRUG LABEL |
| IMIPENEM - Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | Fresenius Kabi USA, LLC | ACS Dobfar S.p.A. | Zambon Switzerland Ltd | 2022-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-322-01 | Imipenem and Cilastatin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 20 | 12 | |
| 63323-322-25 | Imipenem and Cilastatin | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 12 | |
| 63323-322-41 | Imipenem and Cilastatin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 20 | 7 | |
| 63323-322-94 | Imipenem and Cilastatin | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 7 | |
| 63323-322-21 | Imipenem and Cilastatin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 20 | 5 | |
| 63323-322-93 | Imipenem and Cilastatin | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-322 | IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 12 | Current NDC, Legacy NDC, 2 package rows | 20221020_6ab0ca9e-9a79-4cab-9f09-470eda06952e.zip |
| 63323-322 | IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20221027_0a1dd9b9-ada1-4bff-9dcb-18961254e9e8.zip |
| 63323-322 | IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20221103_ce771566-c4f2-447e-944a-6b908925c90b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-322-01 | EA - Each | 63323-322 | 34deeaf8-735f-4d5d-8ce0-f7bca735d05f | 1 | 2022-01-06 |
| 63323-322-20 | EA - Each | 63323-322 | 15d13752-d665-47b7-a49c-deac99c4cf15 | 1 | 2012-07-24 |
| 63323-322-21 | EA - Each | 63323-322 | f295eda5-5f73-456c-93a6-9c36771eb017 | 1 | 2022-04-06 |
| 63323-322-25 | EA - Each | 63323-322 | 3224fb37-f888-4ac9-943f-4fd3d043976d | 1 | 2013-02-13 |
| 63323-322-41 | EA - Each | 63323-322 | 1036c74b-ed3a-40f7-bbf1-87d3249cda17 | 1 | 2022-10-06 |
| 63323-322-93 | EA - Each | 63323-322 | 09ffc170-6c97-4df2-939c-49e83a8a41f7 | 1 | 2016-07-19 |
| 63323-322-94 | EA - Each | 63323-322 | 89f6cade-0bdd-4c18-b4ce-d0e9ff9c7655 | 1 | 2015-01-05 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | ScieGen Pharmaceuticals, Inc. | a107804e-b308-4e79-9447-07d93016f70f | 2024-10-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 53380470-5748-6fa7-548e-7484ef204c0f | 2024-10-21 | Warnings | 8MDF5V39QO |
| OHTAS ISAN ANTACID | CALCIUM CARBONATE, SODIUM BICARBONATE | OHTA'S ISAN CO.,LTD. | 8723fe90-8402-4511-b6c6-b71cf98513e3 | 2024-10-21 | Warnings | 8MDF5V39QO |
| Elliotts B | SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE | Lukare Medical, LLC | 08036dbd-55b3-47b9-9890-000f253544f3 | 2024-10-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE INJECTION, | Long Grove Pharmaceuticals, LLC | a26d709b-b294-4b02-9a88-7e840f099a33 | 2024-09-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| Insect sting relief latex 01 | SODIUM BICARBONATE | Cosmuses Cosmetics (Ningbo) Co., Ltd. | 1b9e2d4c-bc0c-6ed0-e063-6294a90a9103 | 2024-08-19 | Warnings | 8MDF5V39QO |
| Quality Choice Effervescent Antacid and Pain Relief - Extra Strength | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association | 1f926637-a61c-8eb7-e063-6394a90a6502 | 2024-08-13 | Warnings | 8MDF5V39QO |
| Omeprazole/Sodiium Bicarbonate | OMEPRAZOLE/SODIIUM BICARBONATE | Direct_rx | 1f7f63c1-17c2-9a05-e063-6394a90abc6f | 2024-08-12 | Warnings, Adverse reactions | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | ddee28fb-c871-a6d4-984f-515522b28412 | 2024-07-15 | Warnings | 8MDF5V39QO |
| PRIMAXIN IV | IMIPENEM AND CILASTATIN SODIUM | Merck Sharp & Dohme LLC | f41d8abd-7792-4918-1b93-bd83ea01955e | 2024-07-05 | Warnings, Adverse reactions | 1726204 71OTZ9ZE0A 5428WXZ74M |
| Insect sting relief pad 01 | SODIUM BICARBONATE | Cosmuses Cosmetics (Ningbo) Co., Ltd. | 1b0f0088-6482-6de7-e063-6294a90aeeb7 | 2024-06-17 | Warnings | 8MDF5V39QO |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | ANI Pharmaceuticals, Inc. | 63c3bd6c-a586-4ec0-8f45-ed936936dfeb | 2024-06-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Sun Pharmaceutical Industries Limited | 5ae65432-04a1-4b6b-8536-2535064fc782 | 2024-03-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Steriscience Specialties Private Limited | eb2996b4-c04c-4678-b8a9-5cbbe509bb70 | 2024-03-04 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Bryant Ranch Prepack | 4493d7c5-f2c3-416e-a5c1-35398fc7f61d | 2024-02-29 | Boxed warning, Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | a5eedf57-2783-b3d0-e053-2a95a90a9ff5 | 2024-02-22 | Warnings, Adverse reactions | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 76131655-3a87-feac-e053-2991aa0a82a1 | 2024-01-28 | Warnings, Adverse reactions | 8MDF5V39QO |
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Pharma Nobis, LLC | e42f674b-1a70-6a3c-e053-2995a90afa72 | 2023-12-22 | Warnings | 8MDF5V39QO |
| HEB Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 9e502bd0-8042-8674-e053-2995a90a3d15 | 2023-12-18 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.